Department of Medicine, Institute of Clinical Medicine, University of Tromsø, Tromsø, NorwayDepartment of Bacteriology, National Institute of Public Health, Oslo, NorwayInstitute for Infectious Diseases of Children, Regional Hospital, Arkhangelsk, RussiaLaboratory of Epidemiologic Surveillance for Diphtheria, G. N. Gabrichevsky Institute for Epidemiology and Microbiology, Moscow, RussiaMedical Department B, University of Bergen, Haukeland Hospital, Bergen, Norway.
Clin Microbiol Infect. 1999 Oct;5(10):628-33. doi: 10.1111/j.1469-0691.1999.tb00420.x.
To investigate the reliability of the different methods used in Norway and Russia for detection of diphtheria antitoxin.
One hundred and twenty-two sera were selected among Russian serum samples previously collected for seroepidemiologic studies of diphtheria antitoxin. The sera were selected to cover the total antitoxin range and were analyzed by four different antidiphtheria toxin assays: an in vitro toxin neutralization test using Vero cells (in vitro NT), an in vivo neutralization test using rabbit skin inoculation (in vivo NT), an indirect enzyme immunoassay (EIA) and a passive hemagglutination assay (PHA). The results were expressed according to the international standard as: not protected (<0.01 IU/mL), relatively protected (0.01-0.1 IU/mL) or protected (≥0.1 IU/mL). The sensitivity, specificity and inter-rater agreement (K or Kw) of each method were related to the in vitro NT selected as the reference method.
The in vivo NT test corresponded very well with the in vitro NT in its ability to differentiate between protection/relative protection and no protection (sensitivity 97%, specificity 87% and K=0.84). The EIA test showed a high sensitivity (96%), but since many sera were categorized as protected rather than not protected, the specificity (30%) and inter-rater agreement (K=0.29) were low. The PHA test had a very high specificity (100%) but a low sensitivity (86%).
The agreement between the two neutralization tests was high. If none of the neutralization assays is routinely available, the PHA test can be used to predict the need for vaccination on an individual basis but should not be used for seroepidemiologic studies, since the protection rate for diphtheria would be falsely too low, due to the lower sensitivity. The indirect EIA test used in this study should not be used routinely.
研究挪威和俄罗斯用于检测白喉抗毒素的不同方法的可靠性。
从以前为白喉抗毒素血清流行病学研究收集的俄罗斯血清样本中选择了 122 份血清。选择这些血清来覆盖总抗毒素范围,并使用四种不同的抗白喉毒素检测方法进行分析:使用 Vero 细胞的体外毒素中和试验(体外 NT)、使用兔皮接种的体内中和试验(体内 NT)、间接酶免疫测定(EIA)和被动血凝测定(PHA)。结果根据国际标准表示为:未保护(<0.01 IU/mL)、相对保护(0.01-0.1 IU/mL)或保护(≥0.1 IU/mL)。每种方法的敏感性、特异性和评分者间一致性(K 或 Kw)均与体外 NT 相关,体外 NT 被选为参考方法。
体内 NT 试验在区分保护/相对保护和无保护方面与体外 NT 非常吻合(敏感性 97%,特异性 87%,K=0.84)。EIA 试验具有很高的敏感性(96%),但由于许多血清被归类为保护而不是未保护,特异性(30%)和评分者间一致性(K=0.29)较低。PHA 试验具有非常高的特异性(100%),但敏感性(86%)较低。
两种中和试验之间的一致性很高。如果没有常规进行中和检测,则可以使用 PHA 试验来预测个体接种的需求,但不应将其用于血清流行病学研究,因为由于敏感性较低,白喉的保护率将被错误地低估。本研究中使用的间接 EIA 试验不应常规使用。